Anifrolumab
- CAS No.
- 1326232-46-5
- Chemical Name:
- Anifrolumab
- Synonyms
- Anifrolumab;MDX-1333|||MEDI-546;Anifrolumab (anti-IFNAR1);Research Grade Anifrolumab;Research Grade Anifrolumab(DHD23001);Anti-Human IFNAR1 Monoclonal Antibody(Anifrolumab)
- CBNumber:
- CB28080891
- Molecular Formula:
- Molecular Weight:
- 0
- MDL Number:
- MOL File:
- Mol file
- MSDS File:
- SDS
- TDS File:
- TDS
| form | Liquid |
|---|---|
| color | Colorless to light yellow |
| FDA UNII | 38RL9AE51Q |
Anifrolumab price
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| ChemScene | CS-0612583 | Anifrolumab 99.79% | 1326232-46-5 | 1mg | $260 | 2026-06-04 | Buy |
| ChemScene | CS-0612583 | Anifrolumab 99.79% | 1326232-46-5 | 5mg | $585 | 2026-06-04 | Buy |
| ChemScene | CS-0612583 | Anifrolumab 99.79% | 1326232-46-5 | 10mg | $921 | 2026-06-04 | Buy |
| ChemScene | CS-0612583 | Anifrolumab 99.79% | 1326232-46-5 | 25mg | $1733 | 2026-06-04 | Buy |
| ChemScene | CS-0612583 | Anifrolumab 99.79% | 1326232-46-5 | 50mg | $2708 | 2026-06-04 | Buy |
Anifrolumab Chemical Properties, Uses, Production
Uses
Anifrolumab is a type I interferon (IFN) receptor antagonist, a human monoclonal antibody. Anifrolumab blocks the activity of type I interferon. Anifrolumab can be used in systemic lupus erythematosus (SLE) research[1][2].
References
[1] Furie R, et al. Anifrolumab, an Anti-Interferon-α Receptor Monoclonal Antibody, in Moderate-to-Severe Systemic Lupus Erythematosus. Arthritis Rheumatol. 2017 Feb;69(2):376-386. DOI:10.1002/art.39962
[2] Riggs JM, et al. Characterisation of anifrolumab, a fully human anti-interferon receptor antagonist antibody for the treatment of systemic lupus erythematosus. Lupus Sci Med. 2018 Apr 5;5(1):e000261. DOI:10.1136/lupus-2018-000261
Anifrolumab Preparation Products And Raw materials
Raw materials
Preparation Products
Anifrolumab Suppliers
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| Hangzhou Jiabiqi Biotechnology Co., Ltd. | 18143428389 18143428389 | 443228489@qq.com | China | 168 | 58 |
| Shanghai YuanYe Biotechnology Co., Ltd. | 15026964105 | 2881489226@qq.com | China | 89667 | 60 |
| ShangHai Biochempartner Co.,Ltd | 177-54423994 17754423994 | 2853530910@QQ.com | China | 8000 | 62 |
| Beijing Solarbio Science & Tecnology Co., Ltd. | 17801761073 18101056239 | 3193328036@qq.com | China | 28150 | 68 |
| Chemleader Biomedical Co., Limited. | 021-58180488 | sales@MedChemLeader.com | China | 1004 | 58 |
| BOC Sciences | 16314854226; +8616314854226 | inquiry@bocsci.com | United States | 19852 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| Guangzhou Hongyuan Chemical Co.,Ltd | 15817493340 | 981810490@qq.com | China | 1577 | 58 |
| Wuhan Chemstan Biotechnology Co., Ltd. | 027-65317797 15926423062 | 422450190@qq.com | China | 10305 | 58 |
| Beijing Jin Ming Biotechnology Co., Ltd. | 010-60605840 | psaitong@jm-bio.com | China | 27626 | 58 |
View Latest Price from Anifrolumab manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
![]() |
2026-08-14 | Anifrolumab
1326232-46-5
|
$197.00-690.00 | 95.00% | 10g | TargetMol Chemicals Inc. |
-

- Anifrolumab
1326232-46-5
- $197.00-690.00
- 95.00%
- TargetMol Chemicals Inc.




